- Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
- Royalty Pharma Declares Second Quarter 2024 Dividend
- Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
- Royalty Pharma Reports Q4 and Full Year 2023 Results
- Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
- Royalty Pharma Announces Dividend Increase
- Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
- Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
- Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
- Royalty Pharma Reports Third Quarter 2023 Results
More ▼
Key statistics
On Friday, Royalty Pharma PLC (RPRX:NSQ) closed at 28.41, 9.61% above its 52-week low of 25.92, set on Sep 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 28.66 |
---|---|
High | 28.78 |
Low | 28.14 |
Bid | 28.15 |
Offer | 29.00 |
Previous close | 28.76 |
Average volume | 3.19m |
---|---|
Shares outstanding | 597.44m |
Free float | 424.66m |
P/E (TTM) | 11.20 |
Market cap | 16.97bn USD |
EPS (TTM) | 2.54 USD |
Annual div (ADY) | 0.84 USD |
---|---|
Annual div yield (ADY) | 2.96% |
Div ex-date | Feb 15 2024 |
Div pay-date | Mar 15 2024 |
Next div ex-date | May 16 2024 |
Next div pay-date | Jun 14 2024 |
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼